Protalix BioTherapeutics, Inc. financial data

Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2 University Plaza, Suite 100, Hackensack, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ORTHODONTIX INC (to 2/22/2007), EMBASSY ACQUISITION CORP (to 3/31/1998)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 175 % +15.4%
Quick Ratio 49.5 % -6.16%
Debt-to-equity 149 %
Return On Equity 19.5 % -90.4%
Return On Assets 7.82 %
Operating Margin 13.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73.1 M shares +11.7%
Common Stock, Shares, Outstanding 73 M shares +35.6%
Entity Public Float 139 M USD +167%
Common Stock, Value, Issued 73 K USD +35.2%
Weighted Average Number of Shares Outstanding, Basic 73 M shares +27.1%
Weighted Average Number of Shares Outstanding, Diluted 73 M shares +27.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 59.7 M USD +45%
Cost of Revenue 22.5 M USD +35.2%
Research and Development Expense 14.1 M USD -46.5%
Operating Income (Loss) 8.06 M USD -97.5%
Nonoperating Income (Expense) -1.29 M USD +10.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.77 M USD -61.2%
Income Tax Expense (Benefit) -79 K USD -171%
Net Income (Loss) Attributable to Parent 6.85 M USD -46.8%
Earnings Per Share, Basic 0.11 USD/shares -20%
Earnings Per Share, Diluted 0.08 USD/shares -20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.2 M USD -17.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.76 M USD +188%
Inventory, Net 22.3 M USD +10.1%
Other Assets, Current 812 K USD +7.12%
Assets, Current 75.4 M USD +36.1%
Deferred Income Tax Assets, Net 3.23 M USD
Property, Plant and Equipment, Net 4.78 M USD +1.64%
Operating Lease, Right-of-Use Asset 5.88 M USD +13%
Assets 89.8 M USD +35%
Accounts Payable, Current 18.8 M USD
Employee-related Liabilities, Current 2.5 M USD
Accrued Liabilities, Current 8.45 M USD
Contract with Customer, Liability, Current 11 M USD -6.37%
Liabilities, Current 54.8 M USD +74%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 4.5 M USD +8.36%
Liabilities 60 M USD -8.41%
Retained Earnings (Accumulated Deficit) 382 M USD
Stockholders' Equity Attributable to Parent 29.8 M USD +2855%
Liabilities and Equity 89.8 M USD +35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.19 M USD
Net Cash Provided by (Used in) Financing Activities 14.2 M USD
Net Cash Provided by (Used in) Investing Activities -606 K USD -113%
Common Stock, Shares Authorized 185 M shares +28.5%
Common Stock, Shares, Issued 73 M shares +35.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.58 M USD -77.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.2 M USD -17.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 766 K USD -28.9%
Deferred Tax Assets, Valuation Allowance 51.6 M USD -11.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Operating Lease, Liability 6.03 M USD +14.1%
Depreciation 322 K USD +15%
Payments to Acquire Property, Plant, and Equipment 598 K USD +141%
Lessee, Operating Lease, Liability, to be Paid 9.03 M USD +7.28%
Property, Plant and Equipment, Gross 39.7 M USD +3.72%
Operating Lease, Liability, Current 1.45 M USD +26.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.4 M USD +44.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.41 M USD +26%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Deferred Income Tax Expense (Benefit) -138 K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3 M USD -4.15%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13 M USD +16.8%
Deferred Tax Assets, Operating Loss Carryforwards 51.5 M USD -4.85%
Current Income Tax Expense (Benefit) 3.35 M USD
Unrecognized Tax Benefits 805 K USD +51.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.04 M USD +20.7%
Deferred Tax Assets, Net of Valuation Allowance 3.09 M USD